Skip to main content

Home/ Dr. Goodyear/ Group items matching "low-dose" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
Nathan Goodyear

Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression - 0 views

digital.lib.washington.edu/...4415

HCG testosterone ITT intratesticular testosterone

shared by Nathan Goodyear on 15 May 12 - No Cached
  • Nathan Goodyear on 15 May 12
     
    low dose HCG, given every other day, shown to maintain intratesticular testosterone levels (ITT) in this with testosterone induced suppression.  A high ITT:T ratio is needed for appropriate spermatogenesis.
Nathan Goodyear

http://www.integratedhealthclinic.com/assets/byCancerType/Pancreatic/4-LDN%20and%20IV%20Alpha%20Lipoic%20Acid.pdf - 0 views

www.integratedhealthclinic.com/...IV%20Alpha%20Lipoic%20Acid.pdf

alpha lipoic acid ALA cancer pancreatic LDN low dose naltrexone selenium milk thistle silymarin IV intravenous

shared by Nathan Goodyear on 10 Feb 14 - No Cached
  • Nathan Goodyear on 10 Feb 14
     
    Author describes the long-term survival of a man with metastatic pancreatic cancer using IV alpha lipoic acid, low dose naltrexone, diet, and oral triple therapy of milk thistle, ALA, and selenium.  The safety profile is very good as compared to traditional therapy for metastatic pancreatic cancer.
Nathan Goodyear

Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains - 0 views

www.jimmunol.org/...2080.long

estrogen therapy autoimmune

shared by Nathan Goodyear on 15 Jul 13 - No Cached
  • Nathan Goodyear on 15 Jul 13
     
    Low dose estrogen therapy to reduce autoinflammatory T cells in rat model with autoimmune encephalomyelitis.
Nathan Goodyear

Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidase - 0 views

www.biomedcentral.com/...1742-2094-9-32.pdf

LDN low dose naltrexone immune system autoimmune disease inflammation superoxide

shared by Nathan Goodyear on 31 Jul 13 - No Cached
  • Nathan Goodyear on 31 Jul 13
     
    Low dose naltrexone is immune modulator. This study proposes the biochemistry of immune cell suppression through superoxide inhibition.
Nathan Goodyear

Low dose of bisphenol A impairs the reprod... [J Physiol Biochem. 2013] - PubMed - NCBI - 0 views

www.ncbi.nlm.nih.gov/...24271643

BPA bisphenol A

shared by Nathan Goodyear on 29 Nov 13 - No Cached
  • Nathan Goodyear on 29 Nov 13
     
    BPA shown to effect HPA in rats.  The effects were seen as a result of pre and post natal exposure of low dose bisphenol A.  Testosterone was not found to be negatively impacted.  
Nathan Goodyear

Low-Dose Transdermal Testosterone Therapy Improves Angina Threshold in Men With Chronic Stable Angina - 0 views

circ.ahajournals.org/...1906.abstract

Testosterone therapy angina ST depression heart cardiovascular disease men male hormone hormones

shared by Nathan Goodyear on 03 Dec 13 - No Cached
  • Nathan Goodyear on 03 Dec 13
     
    Small study finds low dose Testosterone, 5 mg over 12 weeks, reduced exercise induce myocardial ischemia through an increase in time to ST segment depression.
Nathan Goodyear

http://www.ldnresearchtrust.org/sites/default/files/LDN_Cancer.pdf - 0 views

www.ldnresearchtrust.org/...LDN_Cancer.pdf

cancer LDN low dose naltrexone naltrexone vitamin D vitamin D

shared by Nathan Goodyear on 01 Oct 14 - No Cached
  • Nathan Goodyear on 01 Oct 14
     
    low dose naltrexone plus vitamin D3 to treat cancer
Nathan Goodyear

Oxytrex Minimizes Physical Dependence While Providing Effective Analgesia: A Randomized Controlled Trial in Low Back Pain - 0 views

www.jpain.org/...abstract

naltrexone pain control opiates

shared by Nathan Goodyear on 19 May 11 - No Cached
  • Active treatment groups attained comparable analgesia despite significantly lower drug use
  • preclinical data also show a suppression of opioid tolerance and dependence
  • Previous clinical data have shown ultralow-dose naltrexone enhances and prolongs oxycodone analgesia,
  • ...1 more annotation...
  • A cellular mechanism of action has been demonstrated to be the prevention of aberrant G protein signaling by mu opioid receptors caused by chronic opioid administration
  • Nathan Goodyear on 19 May 11
     
    low dose naltrexone improves pain control and reduced opioid addiction
Nathan Goodyear

An extensive new literature concerning low-dose ef... [Environ Health Perspect. 2005] - PubMed result - 0 views

www.ncbi.nlm.nih.gov/...16079060

BPA toxic Bisphenol A

shared by Nathan Goodyear on 01 Jul 11 - No Cached
  • reports that the median BPA level in human blood and tissues, including in human fetal blood, is higher than the level that causes adverse effects in mice
  • Nathan Goodyear on 01 Jul 11
     
    low dose exposures of BPA toxic
Nathan Goodyear

PayPerView: A Randomized Study of Low-Dose Subcutaneous lnterleukin-2 Plus Melatonin versus Supportive Care Alone in Metastatic Colorectal Cancer Patients Progressing under 5-Fluorouracil and Folates - Karger Publishers - 0 views

www.karger.com/...227465

IL-2 cancer melatonin colon cancer colorectal cancer

shared by Nathan Goodyear on 09 Nov 18 - No Cached
  • Nathan Goodyear on 09 Nov 18
     
    Percent survival at 1 year was significantly increased in patients treated with immunotherapy than in those treated with supportive care alone (9/25 vs. 3/25, p < 0.05) in study which suggests that low-dose subcutaneous IL-2 plus melatonin may be effective as a second-line therapy to induce tumor regression and to prolong percent survival at 1 year in metastatic colorectal cancer patients progressing under 5-FU and folates
Nathan Goodyear

Immunotherapy with subcutaneous low dose interleukin-2 plus melatonin as salvage therapy of heavily chemotherapy-pretreated ovarian cancer - 0 views

www.spandidos-publications.com/...947

cancer IL-2 immunotherapy melatonin ovarian cancer

shared by Nathan Goodyear on 10 May 18 - No Cached
  • Nathan Goodyear on 10 May 18
     
    Small phase II pilot sutyd of advanced ovarian cancer, foud low dose IL-2 at 3 million IU/day X 6 days for 4 weeks preceded by 40 mg melatonin provides some benefit in advanced disease following at least 3 failed polychemotherapy regimens.  
Nathan Goodyear

Immunotherapy with low-dose interleukin-2 in association with melatonin as salvage therapy for metastatic soft tissue sarcomas - 0 views

www.spandidos-publications.com/...157

melatonin cancer IL-2 immunotherapy

shared by Nathan Goodyear on 10 May 18 - No Cached
  • Nathan Goodyear on 10 May 18
     
    Study, again of advanced cancer, with previous failed chemotherapy found that melatonin plus low-dose IL-2 therapy stimulated lymphocyte production and provided a partial response and stable disease.  No control group.
Nathan Goodyear

Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells - PubMed - 0 views

pubmed.ncbi.nlm.nih.gov/31600167

myeloid-derived suppressor cells glioblastoma multiforme metronomic chemotherapy low-dose chemotherapy MDSC glioblastoma

shared by Nathan Goodyear on 08 Nov 20 - No Cached
  • Nathan Goodyear on 08 Nov 20
     
    Low-dose, metronomic chemotherapy induces suppression of MDSCs in the TME in glioblastoma.
Nathan Goodyear

Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells | Journal of Experimental Medicine | Rockefeller University Press - 0 views

rupress.org/...erapy-prevents-therapy-induced

cancer metronomic chemotherapy low-dose chemotherapy

shared by Nathan Goodyear on 20 Sep 20 - No Cached
  • Nathan Goodyear on 20 Sep 20
     
    Great broad review of anti-cancer effects of low-dose metronomic chemotherapy
Nathan Goodyear

Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity. | Clinical Cancer Research - 0 views

clincancerres.aacrjournals.org/...669

NK cells IL-2

shared by Nathan Goodyear on 27 Aug 20 - No Cached
  • Nathan Goodyear on 27 Aug 20
     
    Low dose IL-2 increases NK cell activity. This is critical in cancer fight.
Nathan Goodyear

Genetically targeted fractionated chemotherapy - 0 views

chemotherapy cancer fractionated chemotherapy low-dose chemotherapy insulin

shared by Nathan Goodyear on 03 Jul 20 - No Cached
  • Nathan Goodyear on 03 Jul 20
     
    Good article review on low-dose or fractionated chemotherapy.
« First ‹ Previous 61 - 80 of 322 Next › Last »
Showing 20▼ items per page